CLVS

Clovis Oncology, Inc. Competitors

$85.37
*  
0.28
0.33%
Get CLVS Alerts
*Delayed - data as of Aug. 4, 2015 9:50 ET  -  Find a broker to begin trading CLVS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CLVS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Clovis Oncology, Inc.

CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Galectin Therapeutics Inc.
GALT: NASDAQ-CM
$ 2.70 -0.08 ▼ 7,739 $ 2.77
$ 2.6201
$ 6.60
$ 2.50
NE 64,071
Galectin Therapeutics Inc.
GALTU: NASDAQ-CM
$ 5.79 unch n/a
n/a
$ 16.25
$ 5.79
NE 6,711
Galectin Therapeutics Inc.
GALTW: NASDAQ-CM
$ .85 unch n/a
n/a
$ 3.37
$ .63
NE 1,275
Galena Biopharma, Inc.
GALE: NASDAQ-CM
$ 1.64 0.01 ▲ 41,033 $ 1.64
$ 1.60
$ 3.16
$ 1.275
NE 265,213
Galmed Pharmaceuticals Ltd.
GLMD: NASDAQ-CM
$ 9.70 -0.18 ▼ 800 $ 9.93
$ 9.70
$ 13.50
$ 4.578
NE 107,670
GenVec, Inc.
GNVC: NASDAQ-CM
$ 2.34 -0.04 ▼ 1,002 $ 2.34
$ 2.34
$ 4.67
$ 1.611
NE 40,412
Geron Corporation
GERN: NASDAQ-GS
$ 4.06 0.05 ▲ 79,785 $ 4.08
$ 4.01
$ 4.67
$ 1.76
NE 641,837
GlaxoSmithKline PLC
GSK: NYSE
$ 43.88 0.37 ▲ 320,774 $ 43.9499
$ 43.79
$ 49.24
$ 41.185
7.26 18,895,518
GlobeImmune, Inc.
GBIM: NASDAQ-CM
$ 3.15 1.03 ▲ 374,565 $ 3.48
$ 2.76
$ 11.16
$ 2.03
NE 18,119
GlycoMimetics, Inc.
GLYC: NASDAQ-GM
$ 7.42 unch n/a
n/a
$ 9.68
$ 6.18
NE 141,106
Grifols, S.A.
GRFS: NASDAQ-GS
$ 33.12 0.19 ▲ 37,845 $ 33.28
$ 32.95
$ 40.48
$ 29.24
19.48 4,329,215
GTx, Inc.
GTXI: NASDAQ-CM
$ 1.10 unch n/a
n/a
$ 1.59
$ .41
NE 154,411
GW Pharmaceuticals Plc
GWPH: NASDAQ-GM
$ 112.545 -0.69 ▼ 17,509 $ 112.87
$ 112.08
$ 133.98
$ 58.16
NE 2,219,500
Heat Biologics, Inc.
HTBX: NASDAQ-CM
$ 6.5157 unch n/a
n/a
$ 10.90
$ 3.60
NE 54,758
Heron Therapeutics, Inc.
HRTX: NASDAQ-CM
$ 33.26 0.26 ▲ 14,504 $ 33.4312
$ 32.91
$ 36.81
$ 6.51
NE 1,180,730
Horizon Pharma plc
HZNP: NASDAQ-GS
$ 35.22 0.05 ▲ 117,931 $ 35.41
$ 34.62
$ 39.49
$ 8.30
NE 5,441,455
Hospira Inc
HSP: NYSE
$ 89.49 -0.04 ▼ 70,423 $ 89.52
$ 89.44
$ 89.68
$ 46.56
37.6 15,475,864
iBio, Inc.
IBIO: AMEX
$ .697 0.02 ▲ 2,123 $ .6999
$ .69
$ 3.48
$ .40
NE 53,498
Ignyta, Inc.
RXDX: NASDAQ-CM
$ 14.24 0.12 ▲ 2,565 $ 14.24
$ 14.02
$ 19.40
$ 6.25
NE 359,731
Immune Design Corp.
IMDZ: NASDAQ-GM
$ 19.57 0.35 ▲ 39,881 $ 20.3001
$ 18.60
$ 40.13
$ 11.55
NE 391,243
Immune Pharmaceuticals Inc.
IMNP: NASDAQ-CM
$ 1.62 -0.04 ▼ 2,800 $ 1.65
$ 1.61
$ 4.10
$ 1.50
NE 39,936
ImmunoCellular Therapeutics, Ltd.
IMUC: AMEX
$ .4721 0.00 ▼ 1,173 $ .4864
$ .4721
$ 1.04
$ .4264
NE 42,609
ImmunoGen, Inc.
IMGN: NASDAQ-GS
$ 16.51 -0.12 ▼ 95,250 $ 16.76
$ 16.41
$ 19.43
$ 5.3432
NE 1,422,914
Impax Laboratories, Inc.
IPXL: NASDAQ-GS
$ 48.865 0.58 ▲ 24,114 $ 48.935
$ 47.78
$ 52.10
$ 22.12
77.56 3,503,718
Imprimis Pharmaceuticals, Inc.
IMMY: NASDAQ-CM
$ 7.84 unch n/a
n/a
$ 9.2399
$ 6.72
NE 74,880